Immuno Cure Holding (hk) Limited

This early-stage trial tests a therapeutic DNA vaccine called ICVAX in 22 adults with HIV who are stable on antiretroviral therapy (ART). The goal is to see if the vaccine is safe and can boost the body's immune response against HIV. Participants receive four vaccine injections o…